Exclusive bulk drugs to be waived from the registration list of bulk products

Published: 2002-03-26 06:59:00

Updated: 2002-03-26 06:59:00

The Korea Food and Administration (KFDA) has announced it will formulate its guideline covering the registration of bulk products (e.g., designation of bulk drugs, requirements for necessary data and scope of waiver) until this June, since the mandatory drug master file (DMF) system will be enfor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK